| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/04/2001 | EP1112354A1 Novel protein kinase molecules and uses therefor |
| 07/04/2001 | EP1112353A2 Recombinant protein production in urine |
| 07/04/2001 | EP1112088A1 Method for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
| 07/04/2001 | EP1112087A2 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor |
| 07/04/2001 | EP1112086A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells |
| 07/04/2001 | EP1112085A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 07/04/2001 | EP1112084A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 07/04/2001 | EP1112078A2 New use |
| 07/04/2001 | EP0756708B1 Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation |
| 07/04/2001 | CN1302328A Flowering locus T(FT) and genetically modified plants having modulated flower development |
| 07/04/2001 | CN1301870A New Relatice protein kinase of human mitogen activated protein kinase and its code sequence |
| 07/04/2001 | CN1301869A New human mitogen activated protein kinase phosphatase and its code sequence |
| 07/04/2001 | CN1301868A Human carbonyl reductase and its code sequence |
| 07/04/2001 | CN1301867A Methionine reductase of human thio-oxidizined peptide chain and its code sequence |
| 07/04/2001 | CN1301863A New polypeptide-dihydropyridine dicarboxylic dehydrogenase 12 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301857A New polypeptide-dihydroflate reductase 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301835A New polypeptide-transglutamin-ase 9 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301832A New polypeptide-isopenicillin N synthetase 9 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301773A Macro preparafion of egg specific antibody by sedimentation-filtering-sulfurphilic chromatography process |
| 07/04/2001 | CN1301772A Antibody of specific identifying development regulating protein qBrn-2 and its preparing method and use |
| 07/04/2001 | CN1301765A New polypeptide-human kazal type inhibitory factor 35 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301764A New polypeptide-human zinc-finger protein 25 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301761A New human chemotaxis factor macrophage inflammatory protein, its coding sequence and use |
| 07/04/2001 | CN1301760A New polypeptide-human cytochrome composing protein 11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301758A New polypeptide-human transport protein 9 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301754A New polypeptide-P53 tumor antigen protein 13 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301751A New polypeptide-cytochrome b559 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301750A New polypeptide-ribosome S11 protein 9 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301742A New polypeptide-acid phosphatase family protein 7 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301715A New polypeptide-I-type aminoacy/tRNA synthetase 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301714A New polypeptide-interferon protein 14 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301711A New polypeptide-staphylocoagulase repeated peptide 14 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301705A Novel polypeptide-cytochrome b 5-13 and polynucleotide coding such polypeptide |
| 07/03/2001 | US6255472 Isolated nucleic acid molecule encoding a human skeletal muscle-specific receptor |
| 07/03/2001 | US6255471 CRFG-1b, a target and marker for chronic renal failure |
| 07/03/2001 | US6255470 Isolated nucleic acid molecule encoding an esophageal cancer associated antigen |
| 07/03/2001 | US6255468 MPROT12 polynucleotides and methods thereof |
| 07/03/2001 | US6255462 Peptide tag for immunodetection and immunopurification |
| 07/03/2001 | US6255461 Immunoglobulin; for use as a diagnostic and therapeutic tool in the treatment of mammalian defects |
| 07/03/2001 | US6255458 High affinity human antibodies and human antibodies against digoxin |
| 07/03/2001 | US6255457 Immunoglobulin for use as diagnositic tool and in preferential drug delivery |
| 07/03/2001 | US6255456 Enzymatic polypeptide; for use in diagnosis, detection, prevention and treatment of cancer and immune defects |
| 07/03/2001 | US6255455 Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof |
| 07/03/2001 | US6255107 An antibody reacting with a cell surface antigen expressed on tryptase and chymase positive human mast cells; treatment of allergic disease, bronchial asthma, allergic rhinitis |
| 07/03/2001 | US6255096 An isolated nucleic acid encoding an amino acid; diagnosis and therapy for progressive mental retardation in conjuction with skeletal deformities |
| 07/03/2001 | US6255072 Nucleotide sequences coding proteolytic polypeptide; for use as diagnostic tool; for the prevention of bacterial infection |
| 07/03/2001 | US6255070 Generating preferential polypeptide; express nucleotide sequences which code preferential polypeptide, recover preferential polypeptide |
| 07/03/2001 | US6255056 Contacting body fluid with antibody which binds analyte of specific amino acid sequence including hydroxylysyl pyridinoline or lysyl pyridinoline, detecting binding and correlating with physiological condition |
| 07/03/2001 | US6255055 Diagnosing breast cancer; evaluate breast tissue for preferential polypeptide expression, compare with expression in noncancerous tissue, an amplified presence of preferential polypeptide in tissue indicates cancer |
| 07/03/2001 | US6255046 Drug screening of enzyme inhibitors by expressing enzyme or kinase domain, purifying, isolating, adding test compound and fructose 6-phosphate, and measuring formation of fructose 2,6 bisphosphate product; reduction indicates candidate |
| 07/03/2001 | US6254872 Protective immune response against infections |
| 07/03/2001 | US6254868 Monoclonal antibodies |
| 07/03/2001 | US6254867 Human monoclonal antibodies to the hepatitis B surface antigen |
| 07/03/2001 | US6254861 Hematopoietic growth factor derived from T lymphocytes |
| 07/03/2001 | CA2291144C Topical treatment of psoriasis using neutralizing antibodies to il-8 |
| 07/03/2001 | CA2185568C Chlamydia vaccines and process |
| 07/03/2001 | CA2116348C Sirs vaccine and diagnosis method |
| 07/03/2001 | CA2012993C Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/28/2001 | WO2001046696A2 Methods and compositions for detecting hepatitis e virus |
| 06/28/2001 | WO2001046475A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046454A1 P2y12 receptor |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046422A1 Novel cytokine zcyto18 |
| 06/28/2001 | WO2001046420A2 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 06/28/2001 | WO2001046397A2 Human kinases |
| 06/28/2001 | WO2001046394A2 Mammalian protein phosphatases |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046357A2 Detergent compositions comprising benefit agents |
| 06/28/2001 | WO2001046261A1 Method for treating inflammation |
| 06/28/2001 | WO2001046260A2 Novel immunoglobulin superfamily members apex-1, apex-2 and apex-3 and uses thereof |
| 06/28/2001 | WO2001046259A1 Anti-muc5b antibody and assay of muc5b mucin in mucus and other bodily secretions |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046254A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046233A1 Receptor-like protein kinases from nicotiana tabacum |
| 06/28/2001 | WO2001046232A2 Soluble interleukin-20 receptor |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046224A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001046221A1 Protein methylarginine-specific antibodies |
| 06/28/2001 | WO2001045747A1 Interferon gamma inducing factor based vaccine and use of same for protective immunity against multiple sclerosis |
| 06/28/2001 | WO2001045746A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/28/2001 | WO2001045730A2 Tweak receptor |
| 06/28/2001 | WO2001045669A1 Therapeutic use of particles displaying pathogen-specific binding moieties |
| 06/28/2001 | WO2001040464A8 Interleukin-1-receptor associated kinase-3 (irak3) and its use in promotion or inhibition of angiogenesis and cardiovascularization |
| 06/28/2001 | WO2001004148A3 Donor strand complemented pilin and adhesin broad-based vaccines |
| 06/28/2001 | WO2001002561A3 Mammalian calcium channels and related probes, cell lines and methods |
| 06/28/2001 | WO2000075658A3 Detection of ryanodine receptor antibodies |
| 06/28/2001 | WO2000075305A3 Candida albicans genes and proteins coded by said genes |
| 06/28/2001 | WO2000073452A3 Compositions and methods for the treatment of immune related diseases |
| 06/28/2001 | WO2000073344A3 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 06/28/2001 | WO2000071741A3 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000068247A3 Serine proteases |
| 06/28/2001 | WO2000067697A3 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 06/28/2001 | WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO1999064461A9 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |